Transgene SA (TRGNF)
Transgene Market Cap: 132.29M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| DBV Technologies SA | 630.42M |
| Cellectis SA | 438.42M |
| Innate Pharma SA | 166.80M |
| Inventiva SA | 1.030B |
| Nanobiotix SA | 1.035B |
Market Cap Related Metrics
| PS Ratio | 1122.44 |
| Price | 1.00 |
| Earnings Yield | -30.25% |